FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets

29,056 resources

Source: Text:

By Version

By Authority

By Realm

 

Start Prev Rows 19400 - 19600 Next

PackageVersionIdentityName/TitleStatusFMMWGDateRealmAuthSource(s)
us.cdc.phinvadsR42.16.840.1.114222.4.11.7638Seafood Source (FDD)active2017-01ustho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1146.181Coccidioidomycosis (Disorders) (SNOMED)active2024-01ushl7sct
us.nlm.vsacR42.16.840.1.113883.1.11.20.22HPDocumentTypeactive2025-04ushl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.9.31ConsultDocumentTypeactive2025-03ushl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.6.1ProcedureNoteDocumentTypeCodesactive2024-06ushl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.4.1DischargeSummaryDocumentTypeCodeactive2024-06ushl7loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7490Clinical Syndrome - Secondary (Arbovirus)active2016-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7332Setting of Further Spreadactive2015-01ussct tho oid
ans.fr.nosR4JDV-J172-SecteurActivite-EPARSJDV_J172-SecteurActivite-EPARSactive2024-12frnational
ans.fr.nosR4JDV-J130-CNAMAmeliSecteurConventionnement-RASSJDV_J130-CNAMAmeliSecteurConventionnement-RASSactive2020-11frnational
ans.fr.nosR4JDV-J218-CNAMAmeliSecteurConventionnement-RORJDV_J218-CNAMAmeliSecteurConventionnement-RORactive2022-08frnational
ans.fr.nosR4JDV-J101-SecteurActivite-RASSJDV_J101-SecteurActivite-RASSactive2024-12frnational
hl7.fhir.uv.emedicinal-product-infoR5sectionCodeSection Codesactive2025-07uvhl7loinc
hl7.fhir.us.splR5splSectionCodesSPL Section Codestrial-use1brr2025-07ushl7loinc
hl7.fhir.us.ndhR4NdhSecureExchangeArtifactsVSSecure Exchange Artifacts Value Settrial-usepa2025-07ushl7fhir
hl7.fhir.uv.security-label-ds4pR4valueset-security-authorizationSecurity Authorization Policy ValueSettrial-use2sec2020-03uvhl7tho
hl7.fhir.uv.security-label-ds4pR4valueset-security-label-markSecurity Label Mark ValueSettrial-use2sec2020-03uvhl7tho
de.gematik.terminologyR4epa-mhd-security-label-vsMHD Security Label Value Set for ePAactive2025-05deinternal
hl7.terminologyR5v3-SecurityCategoryObservationValueSecurityCategoryObservationValueactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityClassificationObservationValueSecurityClassificationObservationValueactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityControlObservationValueSecurityControlObservationValueactive2014-03uvhl7tho
hl7.terminologyR5v3-SecurityIntegrityStatusObservationSecurityIntegrityStatusObservationactive2014-03uvhl7tho
ca.ab.fhir.psabR4security-labelSecurityLabeldraft2024-06cahl7tho
us.nlm.vsacR42.16.840.1.113883.11.20.9.29DIRQuantityMeasurementTypeCodesactive2024-06ushl7sct
de.dktk.oncologyR4ValueSet-onco-core-ValueSet-SeitenlokalisationVSSeitenlokalisationVSactive
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4periwoundConditionVSReriwoundConditionvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundBedAppearanceVSWoundBedAppearanceValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundAssessmentInterpretationVSWoundAssessmentInterpretationvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundTypeEtiologyVSWoundTypeEtiologyvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundGradationVSWoundGradationValueSetdraft2019-06ushl7sct
hl7.fhir.us.vitalsR4definedLimitsVSDefined Limits value setdraft2024-10ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4clockFacePositionVSClockFacePositionValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateOdorVSWoundExudateOdorValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4presentAbsentVSPresentAbsentValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4episodeVSEpisodevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4trendVSTrendvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundInternalItemOrBodyStructureVisibleVSWoundInternalItemOrBodyStructureVisiblevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundEdgeDescriptionVSWoundEdgeDescriptionValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateColorVSWoundExudateColorValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateAppearanceVSWoundExudateAppearanceValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundMeasurementDeviceVSWoundMeasurementDeviceValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundBedColorVSWound Bed Color value setdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundEdgeColorVSWoundEdgeColorValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundShapeVSWound Shape value setdraft2019-09ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundExudateAmountDescriptionVSWoundExudateAmountDescriptionValueSetdraft2019-06ushl7sct
hl7.fhir.us.vitalsR4sPO2BodyLocationVSOxygen Saturation Body Location value setdraft2024-10ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4courseVSCoursevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLocationQualifierVSBodyLocationQualifiervaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundTypeVSCIMIWoundTypevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLocationOrientationVSBodyLocationOrientationvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4underlyingAnatomicalStructureVSUnderlyingAnatomicalStructurevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4pressureUlcerAssociationVSPressureUlcerAssociationvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodySideVSBodySidevaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4qualitativeWoundDepthVSQualitativeWoundDepthvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4woundAnatomicLocationVSWoundAnatomicLocationvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4yesNoVSYesNoValueSetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4surfaceOrientationVSSurfaceOrientationvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4bodyLandmarkDescriptionVSBodyLandmarkDescriptionvaluesetdraft2019-06ushl7sct
hl7.fhir.us.lower-extremity-skin-wound-assessmentR4recurrenceVSRecurrencevaluesetdraft2019-06ushl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7959Underlying Condition(s) (Leptospirosis)active2020-01ussct tho
fhir.r4.ukcore.stu3.currentbuildR4UKCore-ObservationTypeUK Core Observation Typeactive2023-04ushl7sct
fhir.r4.ukcore.stu3.currentbuildR4UKCore-ObservationMethodUK Core Observation Methodretired2023-11ushl7sct
signal.core.r4R4questionnaire-ccars-sexual-orientationQuestionnaire CCARS Sexual Orientationdraft1paushl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.1103Semantic Clinical Drug (Ingredient plus strength and dose form)active2020-01usrx
us.cdc.phinvadsR42.16.840.1.114222.4.11.1104Semantic Clinical Drug Form (Ingredient plus dose form)active2020-01usrx
hl7.fhir.us.davinci-drug-formularyR4SemanticDrugFormGroupVSSemantic Drug Form Group Codestrial-usephx2025-02ushl7rx
hl7.fhir.us.davinci-drug-formularyR4NonPackSemanticDrugVSNon-Pack Semantic Drug Codestrial-usephx2025-02ushl7rx
hl7.fhir.us.davinci-drug-formularyR4SemanticDrugVSSemantic Drug Codestrial-usephx2025-02ushl7fhir rx
hl7.terminologyR5v3-ActClassActionActClassActionactive2014-03uvhl7tho
hl7.terminologyR5v3-ActClassInformationActClassInformationactive2014-03uvhl7tho
hl7.terminologyR5v3-ActClassStateTransitionControlActClassStateTransitionControlactive2014-03uvhl7tho
hl7.terminologyR5v3-InformationSensitivityPolicyInformationSensitivityPolicyactive2014-03uvhl7tho
hl7.fhir.us.military-serviceR4military-service-separation-reason-vsSeparation Reason Value Setactive2023-05ushl7fhir
us.nlm.vsacR42.16.840.1.113762.1.4.1290.5Septic Shockactive2025-04ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1290.6Septic Shockactive2025-04ushl7icd
de.medizininformatikinitiative.kerndatensatz.mikrobiologieR4mii-vs-mikrobio-befundtyp-loincMII VS Mikrobio Befundtyp [LOINC]activedeloinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7706Sequelae (RIBD)active2018-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7773Serogroup Method (RIBD)active2018-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7736Serotype Method (RIBD)active2018-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.3320Serotype Method (IPD)active2010-01ussct tho oid
ans.fr.nosR4JDV-J189-TemporaliteCapacite-RORJDV_J189-TemporaliteCapacite-RORactive2023-09frnational
us.cdc.phinvadsR42.16.840.1.114222.4.11.7477Positive Negative 4 Fold Rise Not Doneactive2016-01ussct oid
ca.on.oh.corhealthR4CorHealth23ServiceDetailVSService Detailactive
MyHIE.v4-testR4value-set-servicerequest-category-my-coreValueSetServiceRequestCategory( MY Core)active2023-01
IdHIE.0vR4value-set-servicerequest-category-id-coreValueSetServiceRequestCategory( ID Core)active2023-06
us.cdc.phinvadsR42.16.840.1.114222.4.11.3227Location performing blood or body fluid exposure procedureactive2009-01ustho
de.gematik.epaR4epa-auditevent-service-type-vsEPA AuditEvent Service Typeactive2025-05deinternal
myhie.v4R4value-set-service-request-type-my-coreValueSetServiceRequestTypeMyCoreactive2024-04
kbv.mio.u-heftR4KBV_VS_MIO_CMR_Service_Request_StatusService-Request Statusactivefhir
hl7.fhir.au.baseR4au-v3-ServiceDeliveryLocationRoleType-extendedServiceDeliveryLocationRoleType - AU Extendedtrial-use12025-06auhl7tho
hl7.fhir.us.breast-radiologyR4ServiceRecommendationsVSServiceRecommendations ValueSetactive2022-12ushl7fhir
hl7.fhir.au.ereqR4au-erequesting-request-statusAU eRequesting RequestStatusdraft02024-11auhl7fhir
dk.ehealth.sundhed.fhir.ig.coreR4ehealth-trigger-enablement-codeTrigger Enablement Codeactive2021-10dk
hl7.fhir.cl.agendaR4VSServiciosVS SERVICIOSactive2025-07clhl7internal
hl7.fhir.cl.minsal.r2boR4r2bo-caracteristicas-margen-quirurgico-VSSet de Valores de Caracteristicas del Margen Quirurgicoinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-categorias-pTNM-VSSet de Valores para Categorias pTNMinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-estructuras-anatomincas-VSSet de Valores Para los Sitios del Cuerpoinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-morfologico-VSSet de Valores de Snomed CT para Anomalías Morfológicainformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-tnm-categoria-nodo-regional-patologico-vsSet de Valores Categoría TNM Patológico Nodos Regionalinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-tnm-categoria-metastasis-distante-patologico-vsSet de Valores Categoría TNM Patológico Metastásico Distanteinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-tnm-categoria-tumor-primario-patologico-vsSet de Valores Categoría TNM Patológico Tumor Primarioinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-cie10-vsSet de Valores de la Clasificación Internacional de Enfermedades 10 Versióninformativeoo2025-08clhl7icd
hl7.fhir.cl.minsal.r2boR4r2bo-cieo3-VSSet de Valores de la Clasificación Internacional de Enfermedades Oncológicas 3ra Edicióninformativeoo2025-08clhl7tho
hl7.fhir.cl.minsal.r2boR4r2bo-topografica-cieo-VSSet de Valores para Topografíainformativeoo2025-08clhl7internal
hl7.fhir.cl.minsal.r2boR4r2bo-topografica-VSSet de Valores de Snomed CT para Topografíainformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-metodos-medicion-VSSet de Valores de los Metodos de Medición del Tumorinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-procedimientos-biopsias-VSSet de Valores Para Procedimientosinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-tipo-procedimientos-biopsias-VSSet de Valores Para Tipo de Procedimientosinformativeoo2025-08clhl7sct
hl7.fhir.cl.minsal.r2boR4r2bo-morfologicosct-cieo-VSSet de Valores Morfologíainformativeoo2025-08clhl7internal
hl7.fhir.uv.phenomics-exchangeR4OnsetOnset ValueSetdraftcic2021-06uvhl7gene sct
hl7.terminologyR5v3-immunizationForecastDateimmunizationForecastDateactive2013-03uvhl7loinc
hl7.fhir.uv.symptomsR5AffectiveGradeAffective Gradeinformativecic2025-08uvhl7loinc
hl7.fhir.uv.symptomsR5FunctionalFindingFunctional Impactinformativecic2025-08uvhl7sct
hl7.terminologyR5v3-ActIncidentCodeActIncidentCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-ActInsurancePolicyCodeActInsurancePolicyCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-SpecimenAdditiveEntitySpecimenAdditiveEntityactive2014-03uvhl7tho
hl7.terminologyR5v3-ActSpecimenTreatmentCodeActSpecimenTreatmentCodeactive2014-03uvhl7tho
hl7.terminologyR5v3-ConfidentialityConfidentialityactive2014-03uvhl7tho
hl7.fhir.us.ecrR4valueset-ersd-endpoint-connection-typeeRSD Endpoint Connection Type Codesactive2020-08ushl7fhir tho
hl7.terminologyR5handling-conditionHandlingConditionSetactive1oo2024-04uvhl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1146.1077Poisoning or Overdose by Other Opioids (Organism or Substance in Lab Results)active2023-01ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1146.304Pesticide Related Illness (Disorders) (SNOMED)active2023-01ushl7sct
openehr.baseR5settingSettinginformative3fhir2024-08uvhl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7807Bird Exposure Setting (RIBD)active2018-01usoid
dk.fhir.ig.kl.common.caresocialR4KLSeveritiesKLSeveritiesactive2020-10
kl.dk.fhir.termR4KLSeveritiesKLSværhedgraderactive2024-10dkinternal
kl.dk.fhir.coreR4KLSeveritiesKLSværhedgraderactive2023-06dk
dk.fhir.ig.kl.common.caresocialR4KLSeveritiesFFBKLSeveritiesFFBactive2020-10
kl.dk.fhir.termR4KLSeveritiesFFBKLFunktionsevneniveauFFBactive2024-10dkoid
kl.dk.fhir.coreR4KLSeveritiesFFBKLFunktionsevneniveauFFBactive2023-06dk
dk.fhir.ig.kl.common.caresocialR4KLSeveritiesFSIIIKLSeveritiesFSIIIactive2020-10
kl.dk.fhir.termR4KLSeveritiesFSIIIKLFunktionsevneniveauFSIIIactive2024-10dkoid
kl.dk.fhir.coreR4KLSeveritiesFSIIIKLFunktionsevneniveauFSIIIactive2023-06dk
de.geccoR41.2.276.0.76.11.514--20200519223054Condition Severityactivesct
ans.fr.terminologiesR4jdv-hl7-v3-SeverityObservationCode-cisisSeverityObservationCodeactive2025-06frnationaltho
fhir.r4.wales.testR4DataStandardsWales-SexData Standards Wales Sexactive2023-11ushl7
de.geccoR42.16.840.1.113883.3.1937.99.61.65.11.4--20200706120216Birth-Sexactivefhir
ans.fr.nosR4JDV-J143-AdministrativeGender-CISISJDV_J143-AdministrativeGender-CISISactive2021-03frnational
ans.fr.nosR4JDV-J112-SexeAdministratif-ENREGJDV_J112-SexeAdministratif-ENREGactive2020-05frnational
ans.fr.nosR4JDV-J80-Sexe-RASSJDV_J80-Sexe-RASSactive2023-12frnational
hl7.fhir.sami.coreR4Human_sexSexoactive2022-02samihl7
BRCore-01.00.00R4d50deb66-f886-4702-9c21-2ca1bf4496ebSexoactive2020-04fhir
us.cdc.phinvadsR42.16.840.1.114222.4.11.7634Sexual Contact (FDD)active2017-01ustho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3231Disease Type (STD)active2009-01ussct
hl7.fhir.uv.emedicinal-product-infoR5propertyShapeShape of the productactive2025-07uvhl7ncit
hl7.terminologyR5v3-ROIOverlayShapeROIOverlayShapeactive2014-03uvhl7tho
hl7.eu.fhir.unicomR5shelflifetype-spor-vsEMA SPOR Shelf Life Typedraft2025-06euhl7
us.cdc.phinvadsR42.16.840.1.114222.4.11.7639Shellfish Distributed (FDD)active2017-01ustho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1235.619b.well Herpes Zoster Vaccine CN_HD_SNOMEDactive2025-03ushl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1034.561Oral Steroid for Cluster Headacheactive2023-12ushl7rx
us.cdc.phinvadsR42.16.840.1.114222.4.11.7965Sick Animal Type (Leptospirosis)active2020-01ussct tho
fhir.cdc.opioid-cds-r4R4sickle-cell-diseasesSickle-cell diseasesactive2023-05ushl7sct icd
us.cdc.phinvadsR42.16.840.1.114222.4.11.7771Side Effect Time to Onset (TB)active2017-12usoid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7772Side Effect of Treatment (TB)active2018-01ussct tho oid
br.go.ses.coreR4sigla-programa-saudeSigla do Programa de Saúdeactive2025-01brinternal
br.go.ses.medicamentosR4sigla-programa-saudeSigla do Programa de Saúdeactive2025-07brinternal
signal.core.r4R4signal-organization-licenseSignal Organization Licensedraft2023-07ushl7
signal.core.r4R4signal-organization-qualificationSignal Organization Qualificationdraft1paushl7
signal.core.r4R4signal-healthcare-service-typeSignal Healthcare Service Typedraft1paushl7
signal.core.r4R4signal-regionSignal Regiondraftushl7
de.thieme-compliance.anamneseR4SignatureTypeVSSignaturtypendraft
us.cdc.phinvadsR42.16.840.1.114222.4.11.7662Signs and Symptoms (Measles)active2018-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7283Signs and Symptoms (Mumps)active2015-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7284Signs and Symptoms (Pertussis)active2017-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.3240Flu Signs and Symptomsactive2009-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7460Signs Symptoms (Arbovirus)active2016-01ussct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7482Signs Symptoms (Chikungunya)active2016-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7481Signs Symptoms (Dengue)active2016-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7459Signs Symptoms (Zika)active2016-01ussct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7225Signs Symptoms (CS)active2020-01ussct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7723Signs and Symptoms (RIBD)active2018-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7666Signs and Symptoms (Trich)active2018-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7944Signs and Symptoms (COVID-19)active2021-01ussct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8059Signs and Symptoms (Hepatitis)active2021-01ussct oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7649Signs and Symptoms (Rubella)active2018-01ussct tho
de.gevko.eahbR4EAHBVSBefundKomplikationenStatusKomplikationen im aktuellen Behandlungsverlauf - Statusactive2021-05
hl7.fhir.us.directory-queryR4NetworkTypeVSNetwork Type Value Setactive2022-12ushl7fhir
hl7.fhir.us.davinci-pdex-plan-netR4NetworkTypeVSNetwork Type VStrial-usefm2025-02ushl7fhir
hl7.fhir.us.ndhR4NetworkTypeVSNetwork Type Value Settrial-usepa2025-07ushl7tho
hl7.terminologyR5v3-SinusUnspecifiedRouteSinusUnspecifiedRouteactive2014-03uvhl7tho
hl7.fhir.it.terminologyR4who-atcWHO ATCactive2025-06ithl7atc
hl7.fhir.it.terminologyR4oid-ehicPersonalIdEHIC Personal ID (system IDs - oid)active2025-06ithl7ietf
hl7.fhir.it.lab-reportR4oid-ehicPersonalIdEHIC Personal ID (system IDs - oid)active2024-03ithl7ietf
us.cdc.phinvadsR42.16.840.1.114222.4.11.7778Specimen Site (FDD)active2018-01ussct tho oid
signal.core.r4R4procedure-not-performed-reasonProcedure Not Performed Reason (SNOMED-CT)draft1pc2019-10ushl7sct
br.go.ses.coreR4situacao-mercado-trabalhoSituacaoMercadoTrabalhoactive2025-01brinternal
dk.kip.rkkp.fhir.ig.coreR4CoronaryArteryGraphKAG vurderingactive2022-06internal
hl7.terminologyR5v3-SkinRouteSkinRouteactive2014-03uvhl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.8022Skin Smear Interpretation (Hansen)active2020-01usoid
cezih.hr.cezih-osnovaR4mkb10-chronicKronične dijagnozedraft2024-01uv
cezih.hr.cezih-osnovaR4observationsKodovi Opservacijadraft2024-01uv
cezih.hr.cezih-osnovaR4document-sectionKodovi sekcija (dijelova) kliničkog dokumentadraft2024-01uv
cezih.hr.cezih-osnovaR4icd10-hrSkup koncepata MKB-10 dijagnozaactive2024-01uv
cezih.hr.cezih-osnovaR4nacin-prijemaNačin prijemadraft2024-01uv
cezih.hr.cezih-osnovaR4sudjelovanje-u-troskovimaSudjelovanje pacijenta u troškovima liječenjadraft2024-01uv
cezih.hr.cezih-osnovaR4annotation-typeTip zabilješkedraft2024-01uv
cezih.hr.cezih-osnovaR4condition-annotation-typeVrsta zabilješke uz slučajdraft2024-01uv
cezih.hr.cezih-osnovaR4document-typeVrsta dokumentadraft2024-01uv
cezih.hr.cezih-osnovaR4sifra-oslobodjenja-od-sudjelovanja-u-troskovimaŠifra oslobođenja pacijenta od sudjelovanja u troškovima liječenjadraft2024-01uv
cezih.hr.cezih-osnovaR4djelatnosti-zzDjelatnosti zdravstvene zaštitedraft2024-01uv